Clinical Trials in Jilin, Changchun
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Advanced NSCLC
Shanghai Junshi Bioscience Co., Ltd.66 enrolled18 locationsNCT06924606
Recruiting
Not Applicable
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Coronary Artery DiseaseHeart Failure, Systolic
Sunnybrook Health Sciences Centre754 enrolled40 locationsNCT05427370
Recruiting
Phase 1
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
Advanced Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.144 enrolled1 locationNCT05504278